Katherine Knox's guest appearances

Katherine Knox

Rob Hopkins

Gormley - On Demand CJME / CKOM

Researchers Under the Scope

Michael Levin

Alex Wong

Dave Rubin

Wayne Gretzky

Charles Smith

Charles Eisenstein

Michael Mann

Ryan Fisher

Todd Lewis

Sarah Mills

Jason Roberts

Mike Russell

Paul Hawken

Cory Doctorow

Patrick Brown

OwlTail

Multiple Sclerosis affects 1 in 3000 Saskatchewan residents. Katherine Knox, and Sarah Donkers are University of Saskatchewan researchers who are working on bringing physical rehabilitation for MS patients closer to home. Katherine joins us to talk about the NeuroSask program.

Gormley - Katherine Knox - Tuesday, May 31, 2022

When Dr. Katherine Knox first arrived in Saskatchewan more than two decades ago, the province covered one prescription drug for patients with Multiple Sclerosis. Beyond that, patients had to pay for drugs out-of-pocket.   Today, Knox said the province reimburses MS patients for 14 different drugs.   “MS is an expensive disease on many levels,” said Knox, noting Saskatchewan’s coverage is now the most favourable for MS patients anywhere in Canada.   In Saskatchewan, three in 1,000 people have Multiple Sclerosis — one of the highest incidences of Multiple Sclerosis in the world.    As treatments improve, the number of people living with this chronic autoimmune disease is rising.   “It’s probably a combination of genetic and environmental factors that play a role,” said Knox, who first learned about the disease as a student volunteer with the MS Society of Canada.   “Everyone had such a unique disease experience,” Knox said. “So I just became more curious.”   Her research these days focuses on non-drug approaches which prevent the onset of disability.   After 15 years with the disease, it’s estimated roughly half of MS patients need a cane or walking aid.   “Understandably many people don’t want to use a walker for good reason,” said Knox.    “It’s bulky, it’s awkward, it certainly lets people know that you have an issue with your walking.”   To delay that, Knox turned to researchers at the College of Kinesiology’s Biomechanics of Balance and Movement Lab, to look at the power of a ‘light touch’.   The goal is to help people with MS regain — and keep — their balance and mobility.   “Patients would tell us you know when I walk the dog and hold the leash, my balance feels better. Or when I lightly touch the back of the chair I can be re-orientated,” she said.    By teaming up with Dr. Alison Oates, fourth-year resident Najala Orrell, and Pawan Kumar, an engineer and kinesiology research fellow, Knox studies patients’ balance and stability, using various haptic inputs.   “Even just a light touch on a walker or perhaps a different object can help them regain their balance,” said Knox.   In this episode, she said keeping her patients moving and avoiding falls is crucial.   “We do need innovation and technology to come up with ways that can provide sensory feedback that would be discreet, socially acceptable, and easy to use,” said Knox.

When Dr. Katherine Knox first arrived in Saskatchewan more than two decades ago, the province covered one prescription drug for patients with Multiple Sclerosis. Beyond that, patients had to pay for drugs out-of-pocket. Today, Knox said the province reimburses MS patients for 14 different drugs. “MS is an expensive disease on many levels,” said Knox, noting Saskatchewan’s coverage is now the most favourable for MS patients anywhere in Canada. In Saskatchewan, three in 1,000 people have Multiple Sclerosis — one of the highest incidences of Multiple Sclerosis in the world.  As treatments improve, the number of people living with this chronic autoimmune disease is rising. “It’s probably a combination of genetic and environmental factors that play a role,” said Knox, who first learned about the disease as a student volunteer with the MS Society of Canada. “Everyone had such a unique disease experience,” Knox said. “So I just became more curious.” Her research these days focuses on non-drug approaches which prevent the onset of disability. After 15 years with the disease, it’s estimated roughly half of MS patients need a cane or walking aid. “Understandably many people don’t want to use a walker for good reason,” said Knox.  “It’s bulky, it’s awkward, it certainly lets people know that you have an issue with your walking.” To delay that, Knox turned to researchers at the College of Kinesiology’s Biomechanics of Balance and Movement Lab, to look at the power of a ‘light touch’. The goal is to help people with MS regain — and keep — their balance and mobility. “Patients would tell us you know when I walk the dog and hold the leash, my balance feels better. Or when I lightly touch the back of the chair I can be re-orientated,” she said.  By teaming up with Dr. Alison Oates, fourth-year resident Najala Orrell, and Pawan Kumar, an engineer and kinesiology research fellow, Knox studies patients’ balance and stability, using various haptic inputs. “Even just a light touch on a walker or perhaps a different object can help them regain their balance,” said Knox. In this episode, she said keeping her patients moving and avoiding falls is crucial. “We do need innovation and technology to come up with ways that can provide sensory feedback that would be discreet, socially acceptable, and easy to use,” said Knox.

A light touch: Katherine Knox on Multiple Sclerosis research

Katharine Knox of Joseph Rowntree Foundation discusses the Foundation's work on climate change, communities, resilience and social justice.  http://www.jrf.org.uk/topic/climate-change-and-communities

Katharine Knox of Joseph Rowntree Foundation discusses the Foundation's work on climate change, communities, resilience and social justice. <a href="http://www.jrf.org.uk/topic/climate-change-and-communities" rel="nofollow" target="_blank">http://www.jrf.org.uk/topic/climate-change-and-communities</a>

Katherine Knox on climate justice